RSAD2 and systemic lupus erythematosus: All CpG sites except cg10549986 (RSAD2) had either moderately or highly statistically significant differences in methylation when comparing SLE cases to healthy controls for three cell populations: CD4+T-cells, CD19+ B-cells, and CD14+ monocytes [12].